PMID- 19099956 OWN - NLM STAT- MEDLINE DCOM- 20090909 LR - 20131121 IS - 0253-3758 (Print) IS - 0253-3758 (Linking) VI - 36 IP - 2 DP - 2008 Feb TI - [Effects of mTOR inhibitor rapamycin on Smad 3 protein and collagen type I expression in rat myocardial fibroblasts infected with coxsackie virus B 3]. PG - 156-60 AB - OBJECTIVE: Mammalian target of rapamycin (mTOR) plays a central role in controlling cell proliferation, survival and growth. We investigated the role of mTOR signal transduction on viral myocarditis by observing the effect of mTOR inhibitor rapamycin on Smad 3 and collagen type I expression in rat myocardial fibroblasts infected with coxsackievirus B 3 (CVB 3). METHODS: Primary cultured myocardial fibroblasts of SD rats infected with CVB 3 were treated with or without rapamycin. The Smad 3 and collagen type I expression of the cells were determined by RT-PCR and Western blot. RESULTS: (1) mTOR/beta-actin ratio was dose-dependently reduced (1 nmol/L, 0.381 +/- 0.022; 10 nmol/L, 0.282 +/- 0.014; 100 nmol/L, 0.263 +/- 0.012 vs. control 1.45 +/- 0.04, all P < 0.05 vs. control) after 48 hours rapamycin treatments and time-dependently reduced after 10 nmol/L rapamycin treatment (24 h, 0.203 +/- 0.021; 48 h, 0.163 +/- 0.022; 72 h, 0.144 +/- 0.013 vs. 0 h, 0.341 +/- 0.022, all P < 0.05 vs.0 h) in CVB 3 infected myocardial fibroblasts. (2) Smad 3/beta-actin ratio of myocardial fibroblasts was significantly increased in CVB 3 infected cardial fibroblasts and this increase could be significantly attenuated by rapamycin (control, 0.63 +/- 0.06; CVB 3, 1.18 +/- 0.03; CVB 3 + Rapamycin, 0.77 +/- 0.08 by RT-PCR and 0.89 +/- 0.07, 2.27 +/- 0.13 and 0.131 +/- 0.013 by Western blot). Collagen type I/beta-actin ratio was also significantly increased by CVB 3 and this increase could be reversed by rapamycin (1.13 +/- 0.06, 1.303 +/- 0.012, 0.82 +/- 0.03 by RT-PCR). CONCLUSION: Rapamycin can inhibit the Smad 3 and collagen type I expressions in CVB 3 infected myocardial fibroblasts suggesting that the mTOR signal pathway may play an important role in the pathogenesis of CVB 3 induced myocardial fibrosis. FAU - Chen, Chun-yuan AU - Chen CY AD - Department of Paediatric, Third Xiangya Hospital, Central South University, Changsha 410003, China. FAU - Sun, Yue-Nu AU - Sun YN FAU - Yang, Zuo-cheng AU - Yang ZC FAU - Cai, Zi-li AU - Cai ZL LA - chi PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhonghua Xin Xue Guan Bing Za Zhi JT - Zhonghua xin xue guan bing za zhi JID - 7910682 RN - 0 (Collagen Type I) RN - 0 (Smad3 Protein) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - Animals MH - Cells, Cultured MH - Collagen Type I/*metabolism MH - Coxsackievirus Infections/metabolism MH - Enterovirus MH - Female MH - Fibroblasts/*metabolism MH - Male MH - Myoblasts, Cardiac/*metabolism/virology MH - Rats MH - Rats, Sprague-Dawley MH - Signal Transduction MH - Sirolimus/*pharmacology MH - Smad3 Protein/*metabolism EDAT- 2008/12/23 09:00 MHDA- 2009/09/10 06:00 CRDT- 2008/12/23 09:00 PHST- 2008/12/23 09:00 [entrez] PHST- 2008/12/23 09:00 [pubmed] PHST- 2009/09/10 06:00 [medline] PST - ppublish SO - Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Feb;36(2):156-60.